Rates of posttraumatic stress disorder (PTSD) are high among combat Veterans. Estimates of PTSD within Iraq and Afghanistan Veterans suggest that nearly 17% of active duty and over 24% of reserve service members screen positive for PTSD. Among individuals diagnosed with PTSD, the incidence of drug abuse and addiction is markedly elevated, with the highest comorbidity observed for alcohol use disorders, estimated to be as high as 85% in individuals seeking PTSD treatment. When these comorbidities manifest they result in poorer psychological, functional, and treatment outcomes than either disorder alone. Evidence suggests that neurobiological mechanisms, such as dysregulation of specific brain structures (e.g., amygdala, insula, prefrontal cortex, and striatum) appear to play crucial roles in the maintenance and remission of concurrent AD/PTSD. Currently there are no translational imaging studies that have examined whether patterns of brain activation can predict differences in treatment response in this population, and no attempts have been made to link psychotherapeutic interventions to neurobiological targets in AD/PTSD individuals. Therefore, the long- term goal of this line of research is to use neuroimaging tools to advance our ability to provide optimized, targeted interventions that support improved outcomes for Veterans with AD/PTSD. The objective of this proposal, which is a first step in pursuit of this goal, is to measure the brain response to an anticipatory task and an alcohol cue reactivity task before and after treatment for AD/PTSD in order to 1) delineate a neural profile of treatment responsiveness to empirically supported interventions, and 2) to compare the relative effects of an exposure based to a non-exposure based treatment on the neural substrates thought to maintain these disorders. Participants will receive one of two, 8-week-long, treatments within an ongoing, VA-funded, randomized controlled trial designed to compare the effectiveness of an exposure-based psychotherapy (i.e., Concurrent Treatment of PTSD and Substance Use Disorders Using Prolonged Exposure (COPE)) against the widely used psychotherapy, Seeking Safety (SS), that does not include exposure for the treatment of AD/PTSD. We hypothesize that baseline patterns of brain response will relate to the capacity to improve in the context of therapy, and that the sub-components of COPE and SS will differentially affect change in those neural circuits maintaining AD/PTSD.
The proposal aims to determine the neural basis of treatment responsiveness, and neural correlates of change and maintenance in response to exposure and non-exposure based psychotherapy for Veterans with comorbid alcohol dependence and posttraumatic stress disorder. The planned neuroimaging results can 1) enhance the understanding of the etiology of psychiatric disorders gained from vital psychological intervention research, 2) promote knowledge of neurobiological mechanisms of healing, and 3) advance our ability to provide targeted interventions that ultimately support improved outcomes for Veterans. These goals are consistent with the VA's mission to sponsor research examining variables related to pathogenesis, diagnosis, and treatment of neuropsychiatric disorders.
|Stout, Daniel M; Buchsbaum, Monte S; Spadoni, Andrea D et al. (2018) Multimodal canonical correlation reveals converging neural circuitry across trauma-related disorders of affect and cognition. Neurobiol Stress 9:241-250|
|Bomyea, J; Matthews, S C; Buchsbaum, M S et al. (2017) Neural differences underlying face processing in veterans with TBI and co-occurring TBI and PTSD. J Affect Disord 223:130-138|
|Kosheleva, Elena; Spadoni, Andrea D; Strigo, Irina A et al. (2016) Faking bad: The neural correlates of feigning memory impairment. Neuropsychology 30:377-84|
|Spadoni, Andrea D; Kosheleva, Elena; Buchsbaum, Monte S et al. (2015) Neural correlates of malingering in mild traumatic brain injury: A positron emission tomography study. Psychiatry Res 233:367-72|
|Norman, Sonya B; Haller, Moira; Spadoni, Andrea D et al. (2015) Maximizing the utility of a single site randomized controlled psychotherapy trial. Contemp Clin Trials 42:244-51|